# Orchestra BioMed Holdings, Inc.: filings

OBIO · Nasdaq · CIK 1814114 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/obio.md) · [Financials](/companies/obio/financials.md) · [Filings](/companies/obio/filings.md) · [Insiders](/companies/obio/insiders.md)

## Reports and events: 91 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 159, 8-K 43, 3 29, 10-Q 18, 4/A 18, 144 14, CORRESP 13, UPLOAD 10, 425 9, SC 13G 7, 10-K 6, DEFA14A 6, S-8 6, SC 13D/A 5, 3/A 4, 424B3 4, DEF 14A 4, EFFECT 4, S-4/A 4, SCHEDULE 13D/A 4, 424B5 3, ARS 3, SC 13D 3, SC 13G/A 3, SCHEDULE 13G/A 3, 8-K/A 2, S-1 2, S-1/A 2, S-3 2, S-3/A 2, SEC STAFF LETTER 2, 10-K/A 1, 10-Q/A 1, 424B4 1, 5 1, 8-A12B 1, CERT 1, DRS 1, PRE 14A 1, PRER14A 1, S-1MEF 1, S-4 1, SCHEDULE 13G 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-01 | 12:14 ET | [8-K](/filings/0001104659-26-112586.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-112586 |
| 2026-09-08 | 13:30 ET | [8-K](/filings/0001104659-26-105733.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-26-105733 |
| 2026-08-10 | 20:07 ET | [10-Q](/filings/0001104659-26-093357.md) | Quarterly report, period 2026-06-30 | 0001104659-26-093357 |
| 2026-06-23 | 20:52 ET | [8-K](/filings/0001104659-26-076845.md) | 5.07 Shareholder vote results | 0001104659-26-076845 |
| 2026-05-12 | 20:07 ET | [10-Q](/filings/0001104659-26-059382.md) | Quarterly report, period 2026-03-31 | 0001104659-26-059382 |
| 2026-04-29 | 21:37 ET | [SCHEDULE 13D/A](/filings/0001493215-26-000068.md) | Ownership report, active investor, amended | 0001493215-26-000068 |
| 2026-04-29 | 20:30 ET | [DEF 14A](/filings/0001104659-26-051570.md) | Proxy statement, period 2026-06-23 | 0001104659-26-051570 |
| 2026-03-12 | 12:03 ET | [10-K](/filings/0001104659-26-026754.md) | Annual report, period 2025-12-31 | 0001104659-26-026754 |
| 2026-02-25 | 21:28 ET | [SCHEDULE 13D/A](/filings/0001493215-26-000063.md) | Ownership report, active investor, amended | 0001493215-26-000063 |
| 2026-02-13 | 22:00 ET | [8-K](/filings/0001104659-26-015315.md) | 5.02 Departure or appointment of officers or directors | 0001104659-26-015315 |
| 2026-01-12 | 14:12 ET | [8-K](/filings/0001104659-26-002752.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-002752 |
| 2025-11-13 | 13:30 ET | [8-K](/filings/0001104659-25-110907.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-25-110907 |
| 2025-11-10 | 21:06 ET | [10-Q](/filings/0001104659-25-109128.md) | Quarterly report, period 2025-09-30 | 0001104659-25-109128 |
| 2025-10-30 | 11:30 ET | [8-K](/filings/0001104659-25-104016.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-25-104016 |
| 2025-10-28 | 12:12 ET | [8-K](/filings/0001104659-25-102862.md) | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-25-102862 |
| 2025-08-12 | 12:00 ET | [10-Q](/filings/0001558370-25-011148.md) | Quarterly report, period 2025-06-30 | 0001558370-25-011148 |
| 2025-08-06 | 20:29 ET | [SCHEDULE 13D/A](/filings/0001415889-25-021175.md) | Ownership report, active investor, amended | 0001415889-25-021175 |
| 2025-08-04 | 20:15 ET | [8-K](/filings/0001104659-25-073641.md) | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-25-073641 |
| 2025-07-31 | 20:05 ET | [8-K](/filings/0001104659-25-072678.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-25-072678 |
| 2025-06-24 | 20:14 ET | [8-K](/filings/0001104659-25-062105.md) | 5.07 Shareholder vote results | 0001104659-25-062105 |
| 2025-05-12 | 20:05 ET | [10-Q](/filings/0001558370-25-007373.md) | Quarterly report, period 2025-03-31 | 0001558370-25-007373 |
| 2025-05-01 | 21:41 ET | [SCHEDULE 13D/A](/filings/0000950170-25-062060.md) | Ownership report, active investor, amended | 0000950170-25-062060 |
| 2025-04-30 | 20:16 ET | [DEF 14A](/filings/0001104659-25-042530.md) | Proxy statement, period 2025-06-24 | 0001104659-25-042530 |
| 2025-04-29 | 13:18 ET | [8-K](/filings/0001104659-25-040763.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-25-040763 |
| 2025-03-31 | 20:16 ET | [10-K](/filings/0001558370-25-004161.md) | Annual report, period 2024-12-31 | 0001558370-25-004161 |
| 2025-03-03 | 13:01 ET | [8-K](/filings/0001104659-25-019500.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-25-019500 |
| 2025-02-25 | 21:30 ET | [8-K](/filings/0001104659-25-016950.md) | 5.02 Departure or appointment of officers or directors | 0001104659-25-016950 |
| 2025-02-05 | 13:18 ET | [8-K](/filings/0001104659-25-009393.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-25-009393 |
| 2024-11-12 | 21:06 ET | [10-Q](/filings/0001558370-24-015313.md) | Quarterly report, period 2024-09-30 | 0001558370-24-015313 |
| 2024-08-12 | 21:11 ET | [8-K](/filings/0001104659-24-088431.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-24-088431 |
| 2024-08-12 | 20:11 ET | [10-Q](/filings/0001558370-24-011899.md) | Quarterly report, period 2024-06-30 | 0001558370-24-011899 |
| 2024-08-07 | 21:19 ET | [SC 13D/A](/filings/0001193125-24-196045.md) | Ownership report, active investor, amended | 0001193125-24-196045 |
| 2024-08-07 | 21:16 ET | [SC 13D/A](/filings/0001193125-24-196038.md) | Ownership report, active investor, amended | 0001193125-24-196038 |
| 2024-07-30 | 20:15 ET | [8-K](/filings/0001104659-24-083973.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-24-083973 |
| 2024-06-20 | 20:44 ET | [8-K](/filings/0001104659-24-073435.md) | 5.07 Shareholder vote results | 0001104659-24-073435 |
| 2024-06-11 | 12:01 ET | [8-K](/filings/0001104659-24-070204.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-24-070204 |
| 2024-05-13 | 20:38 ET | [10-Q](/filings/0001558370-24-007978.md) | Quarterly report, period 2024-03-31 | 0001558370-24-007978 |
| 2024-04-30 | 20:16 ET | [DEF 14A](/filings/0001104659-24-054945.md) | Proxy statement, period 2024-06-20 | 0001104659-24-054945 |
| 2024-03-29 | 20:44 ET | [8-K](/filings/0001104659-24-041173.md) | 8.01 Other events | 0001104659-24-041173 |
| 2024-03-27 | 20:06 ET | [10-K](/filings/0001558370-24-004083.md) | Annual report, period 2023-12-31 | 0001558370-24-004083 |
| 2024-03-07 | 00:48 ET | [8-K](/filings/0001104659-24-031605.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-24-031605 |
| 2023-11-28 | 00:03 ET | [8-K](/filings/0001104659-23-121331.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001104659-23-121331 |
| 2023-11-14 | 11:02 ET | [8-K](/filings/0001104659-23-117492.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-23-117492 |
| 2023-11-13 | 21:10 ET | [10-Q](/filings/0001558370-23-018829.md) | Quarterly report, period 2023-09-30 | 0001558370-23-018829 |
| 2023-10-10 | 21:18 ET | [8-K](/filings/0001104659-23-108359.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-23-108359 |
| 2023-10-10 | 21:07 ET | [S-1](/filings/0001104659-23-108348.md) | Registration statement | 0001104659-23-108348 |
| 2023-09-19 | 11:35 ET | [8-K](/filings/0001104659-23-101763.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-23-101763 |
| 2023-08-10 | 20:06 ET | [10-Q](/filings/0001558370-23-014496.md) | Quarterly report, period 2023-06-30 | 0001558370-23-014496 |
| 2023-07-13 | 01:36 ET | [8-K/A](/filings/0001104659-23-080462.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-23-080462 |
| 2023-07-12 | 13:59 ET | [8-K](/filings/0001104659-23-080208.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-23-080208 |

Page 1 of 2. [Older](/companies/obio/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:06 ET. No prices; not investment advice.